Comparing Smoking Treatment Programs for Lighter Smokers - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2009

Conditions
Tobacco Use Disorder
Interventions
DRUG

nicotine transdermal system

starting with 21 or 14mg dependent on number of cigarettes per day smoked upon entry in the study; titrated down over 8 weeks.

DRUG

bupropion

150 mg/day X 3 days 300mg/day for 60 days Total 9 weeks

BEHAVIORAL

Medication Management

Brief manual based therapy; four 15 minute session over 10 weeks.

BEHAVIORAL

Mayo Counseling

Manual based therapy; Weekly 30 minute sessions for 10 weeks

DRUG

placebo patch

placebo patch containing no nicotine

DRUG

placebo bupropion

placebo pills

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT00086411 - Comparing Smoking Treatment Programs for Lighter Smokers - 1 | Biotech Hunter | Biotech Hunter